These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32972825)

  • 41. Host susceptibility factors to cutaneous leishmaniasis.
    Jones DE; Elloso MM; Scott P
    Front Biosci; 1998 Nov; 3():D1171-80. PubMed ID: 9820738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Host immune response against leishmaniasis and parasite persistence strategies: A review and assessment of recent research.
    Elmahallawy EK; Alkhaldi AAM; Saleh AA
    Biomed Pharmacother; 2021 Jul; 139():111671. PubMed ID: 33957562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis.
    Chamakh-Ayari R; Bras-Gonçalves R; Bahi-Jaber N; Petitdidier E; Markikou-Ouni W; Aoun K; Moreno J; Carrillo E; Salotra P; Kaushal H; Negi NS; Arevalo J; Falconi-Agapito F; Privat A; Cruz M; Pagniez J; Papierok GM; Rhouma FB; Torres P; Lemesre JL; Chenik M; Meddeb-Garnaoui A
    PLoS One; 2014; 9(5):e92708. PubMed ID: 24786587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru.
    Best I; Privat-Maldonado A; Cruz M; Zimic M; Bras-Gonçalves R; Lemesre JL; Arévalo J
    Front Cell Infect Microbiol; 2018; 8():289. PubMed ID: 30186774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.
    Bittar RC; Nogueira RS; Vieira-Gonçalves R; Pinho-Ribeiro V; Mattos MS; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Mem Inst Oswaldo Cruz; 2007 Aug; 102(5):625-30. PubMed ID: 17710308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Cytokine Network Balance Influences the Fate of
    Paiva MB; Ribeiro-Romão RP; Resende-Vieira L; Braga-Gomes T; Oliveira MP; Saavedra AF; Silva-Couto L; Albuquerque HG; Moreira OC; Pinto EF; Da-Cruz AM; Gomes-Silva A
    Front Immunol; 2021; 12():656919. PubMed ID: 34276650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.
    Maasho K; McMahon-Pratt D; Raita J; Raud M; Britton S; Soong L; Akuffo H
    Clin Exp Immunol; 2003 May; 132(2):316-22. PubMed ID: 12699423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of pathogenesis: differences amongst Leishmania species.
    Colmenares M; Kar S; Goldsmith-Pestana K; McMahon-Pratt D
    Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S3-7. PubMed ID: 12055848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine profile and pathology in human leishmaniasis.
    Ribeiro-de-Jesus A; Almeida RP; Lessa H; Bacellar O; Carvalho EM
    Braz J Med Biol Res; 1998 Jan; 31(1):143-8. PubMed ID: 9686192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic and Functional Profiles of Antigen-Specific CD4
    Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
    Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunopathogenesis of infection with the visceralizing Leishmania species.
    Wilson ME; Jeronimo SM; Pearson RD
    Microb Pathog; 2005 Apr; 38(4):147-60. PubMed ID: 15797810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.
    Cañeda-Guzmán IC; Salaiza-Suazo N; Fernández-Figueroa EA; Carrada-Figueroa G; Aguirre-García M; Becker I
    PLoS One; 2014; 9(11):e112410. PubMed ID: 25397678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In situ cytokines (IL-4, IL-10, IL-12, IFN-γ) and chemokines (MCP-1, MIP-1α) gene expression in human Leishmania (Leishmania) Mexicana infection.
    Valencia-Pacheco G; Loría-Cervera EN; Sosa-Bibiano EI; Canché-Pool EB; Vargas-Gonzalez A; Melby PC; Andrade-Narvaez FJ
    Cytokine; 2014 Sep; 69(1):56-61. PubMed ID: 25022962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production.
    Matos GI; Covas Cde J; Bittar Rde C; Gomes-Silva A; Marques F; Maniero VC; Amato VS; Oliveira-Neto MP; Mattos Mda S; Pirmez C; Sampaio EP; Moraes MO; Da-Cruz AM
    BMC Infect Dis; 2007 Apr; 7():33. PubMed ID: 17456233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease.
    Feijó D; Tibúrcio R; Ampuero M; Brodskyn C; Tavares N
    J Immunol Res; 2016; 2016():3967436. PubMed ID: 26904694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokines and their STATs in cutaneous and visceral leishmaniasis.
    Cummings HE; Tuladhar R; Satoskar AR
    J Biomed Biotechnol; 2010; 2010():294389. PubMed ID: 20300429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis.
    Oliveira WN; Ribeiro LE; Schrieffer A; Machado P; Carvalho EM; Bacellar O
    Cytokine; 2014 Apr; 66(2):127-32. PubMed ID: 24485388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential biomarkers of immune protection in human leishmaniasis.
    Rostami MN; Khamesipour A
    Med Microbiol Immunol; 2021 Jun; 210(2-3):81-100. PubMed ID: 33934238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela.
    Convit J
    Clin Dermatol; 1996; 14(5):479-87. PubMed ID: 8889325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.